ROTTERDAM, The Netherlands (December 10, 2019) - IMCD N.V. ("IMCD" or "Company"), a leading distributor of speciality chemicals and food ingredients, today announces that it successfully completed the acquisition of Swiss pharmaceutical distributor DCS Pharma AG.
With this acquisition IMCD acquired 90% of the shares in DCS Pharma AG. The remaining 10% will follow per 31 December 2021.
Attachment
- PRESS RELEASE_ IMCD completes the acquisition of Swiss based DCS Pharma AG (https://ml-eu.globenewswire.com/Resource/Download/4fd8fbb2-d95e-47ec-9565-1420a14502e2)
